(29 days)
Not Found
No
The 510(k) summary describes a traditional electrosurgery device for ablation, pacing, and sensing, with no mention of AI or ML capabilities in the intended use, device description, or specific sections for AI/ML information.
Yes
The device is intended to ablate cardiac tissue and provide temporary cardiac pacing, both of which are therapeutic interventions.
Yes
The device is described as being used for "sensing, recording, and stimulation during the evaluation of cardiac arrhythmias," which are diagnostic functions. It also mentions "bipolar sensing of the ventricle or the atrium."
No
The device description clearly states it is a hand-held, monopolar, radiofrequency ablation device with a saline irrigation system, indicating it is a physical hardware device, not software only.
Based on the provided information, the Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, monitoring, or treatment of a disease or condition.
- Device Function: The Cardioblate® MAPS device is a surgical tool used directly on cardiac tissue during surgery. Its functions include:
- Ablating cardiac tissue using radiofrequency energy.
- Temporary cardiac pacing, sensing, recording, and stimulation during surgery.
- Lack of Specimen Analysis: The description does not mention the device being used to analyze specimens taken from the body. It interacts directly with the patient's cardiac tissue.
Therefore, the device's intended use and function clearly place it outside the scope of In Vitro Diagnostics. It is a surgical device used for therapeutic and diagnostic procedures performed in vivo (within the living body).
N/A
Intended Use / Indications for Use
The Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device is a sterile, single use electrosurgery device intended to ablate cardiac tissue using radiofrequency energy when connected to the Cardioblate® 68000 Generator or for temporary cardiac pacing, sensing, recording, and stimulation during the evaluation of cardiac arrhythmias during surgery when connected to an external temporary cardiac pacemaker.
Product codes
OCL, LDF
Device Description
The Medtronic Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device is a hand-held, monopolar, radiofrequency ablation device powered by the Cardioblate® 68000 Generator. It has a saline irrigation system that delivers fluid at the contact point between tissue and electrode tip to cool tissue during radiofrequency energy delivery. The device can also be used with the Medtronic Model 2090/2290Programmer/Analyzer and the Medtronic Model 5388/5348 External Temporary Pacemaker for bipolar sensing of the ventricle or the atrium and bipolar stimulation (pacing) of the atrium. The device is intended for intermittent operation. The device is provided sterile, nonpyrogenic, disposable, and for single use only.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cardiac tissue
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
K12145
| 10(k) Summary of Safety and Effectiveness | ||
|---|---|---|
| -- | -- | ------------------------------------------- |
| Date Prepared: | May 11, 2012 |
|---|---|
| Applicant: | Medtronic, Inc. |
| 710 Medtronic Parkway, NE | |
| Minneapolis, MN 55432-5604 | |
| Establishment Registration No. 2135394 | |
| Contact Person: | Mary Donlin |
| Senior Regulatory Affairs Specialist | |
| Phone: (763) 526-9172 | |
| Fax: (763) 367-8147 | |
| E-mail: mary.e.donlin@medtronic.com | |
| Trade Name: | Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing |
| Device, Model 49205 (K090721) | |
| Classification Name: | Electrosurgical, Cutting & Coagulation & Accessories |
| Classification: | Class II, 21 CFR 878.4400 |
| Class II, 21 CFR 870.3680 | |
| Product Code: | OCL |
| LDF | |
| Name of Predicate Device: | Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing |
| Device, Model 49205 (K090721) |
Device Description:
The Medtronic Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device is a hand-held, monopolar, radiofrequency ablation device powered by the Cardioblate® 68000 Generator. It has a saline irrigation system that delivers fluid at the contact point between tissue and electrode tip to cool tissue during radiofrequency energy delivery. The device can also be used with the Medtronic Model 2090/2290Programmer/Analyzer and the Medtronic Model 5388/5348 External Temporary Pacemaker for bipolar sensing of the ventricle or the atrium and bipolar stimulation (pacing) of the atrium. The device is intended for intermittent operation. The device is provided sterile, nonpyrogenic, disposable, and for single use only.
Intended Use:
The Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device is a sterile, single use electrosurgery device intended to ablate cardiac tissue using radiofrequency energy when connected to the Cardioblate® 68000 Generator or for temporary cardiac pacing, recording, and stimulation
Page 1 of 2
section 5-1
Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device Medtronic Confidential
Medtronic Confidential
1
during the evaluation of cardiac arrhythmias during surgery when connected to an external temporary cardiac pacemaker.
Contraindications:
The Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device should not be used for patients that have active endocarditis at time of surgery. The device is contraindicated for ablation in a pool of blood (e.g. through a purse string suture on a beating heart). Effects of this type of ablation have not been studied.
Substantial Equivalence:
The historical changes in this submission did not involve changes to control mechanism, operating principles, energy type, indication process. None required clinical evidence to evaluate Impact to safety and effectiveness. The changes were considered to be routine changes to maintain or Improve device performance based on internal or external feedback and the information generated as oart of design verification and validation activities or technical assessments confirmed these changes did not adversely the device's safety or effectiveness.
Conclusion:
The modifications to the Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device described in this submission have not altered the fundamental scientific or indication of the device. The current device is substantially equivalent to the previously submitted and approved predicate Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device, Model 49205 (K090721),
Page 2 of 2
section 5-2
Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device Medtronic Confidential
Medironic Confidential
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its body and wing. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the eagle symbol. The text is in all capital letters and is evenly spaced around the circle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
JUN 1 4 2012
Medtronic, Inc. c/o Ms. Mary Donlin Senior Regulatory Affairs Specialist 710 Medtronic Parkway, NE Minneapolis, MN 55432
Re: K121451
Trade/Device Name: Cardioblate MAPS Surgical Mapping, Ablation, Pacing, ans Sensing Device, Model 49205 Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories. Regulatory Class: Class II (two) Product Code: OCL, LDF Dated: May 15, 2012 Received: May 16, 2012
Dear Ms. Donlin:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Ms. Mary Donlin
Please be advised that FDA's issuance of a substantial equivalence determination does not mean r tease be action and its mination that your device complies with other requirements of the Act that I Dr has intact a and regulations administered by other Federal agencies. You must or any I with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set de recordines and verse overses (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part note the regulation interest - interesting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the I va may overni only generational and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Bram D. Zuckerman, M.D.
Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Statement of Indications for Use
X 12145
K12XXXXX 510(k) Number:
Device Name:
Medtronic Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device, Model 49205
Indications for use:
The Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device is a sterile, single use electrosurgery device intended to ablate cardiac tissue using radiofrequency energy when connected to the Cardioblate® 68000 Generator or for temporary cardiac pacing, sensing, recording, and stimulation during the evaluation of cardiac arrhythmias during surgery when connected to an external temporary cardiac pacemaker.
Prescription Use_ X Per 21 CFR 801.109
Over-The-Counter Use
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of the CDRH, Office of Device Evaluation (ODE)
(Division System)
Division of Cardiovascular Devices
or
510(k) Number: K121451
Page 1 of 1
Section 1-3
Cardioblate® MAPS Surgical Mapping, Ablation, Pacing, and Sensing Device Medtronic Confidential